Table 1. Baseline Participants’ Characteristics.
Characteristics | Study Groups | ||||
---|---|---|---|---|---|
Intervention [N = 368] | Control [N = 330] | ||||
Frequency | % (95% CI) | Frequency | % (95% CI) | ||
Female | 158 | 43 (38–48) | 139 | 42(37–48) | |
Gender | Male | 210 | 57(52–62) | 191 | 58(53–63) |
18–24 | 98 | 27(22–31) | 95 | 29(24–34) | |
25–34 | 144 | 39(34–44) | 120 | 36(31–42) | |
Age Group (in year) | 35–44 | 72 | 20(16–24) | 64 | 19(16–24) |
≥45 | 54 | 15(11–19) | 50 | 15(12–19) | |
Education Status | Elementary & Less | 213 | 58(53–63) | 177 | 54(48–60) |
High School | 119 | 32(28–37) | 105 | 32(27–37) | |
Diploma & Above | 36 | 10(7–13) | 48 | 15(11–19) | |
Married | 123 | 33(29–38) | 101 | 31(26–36) | |
Marital Status | Unmarried | 245 | 67(62–71) | 229 | 69(64–74) |
Employed | 175 | 48(43–53) | 150 | 46(40–51) | |
Employment Status | Unemployed | 141 | 38(34–43) | 153 | 46(41–52) |
Daily Labor | 52 | 14(11–18) | 27 | 8(6–12) | |
None Reactive | 274 | 75(70–79) | 274 | 83(79–87) | |
HIV Serostatus | Reactive | 94 | 26(21–30) | 56 | 17 (13–21) |
ART Status | Not on ART | 286 | 78(73–82) | 231 | 70(65–75) |
On ART | 61 | 18(13–21) | 42 | 13(10–17) | |
New | 279 | 76(71–80) | 248 | 75(70–80) | |
TB Treatment History | Previously Treated | 89 | 24(20–29) | 82 | 25(21–30) |
Pulmonary | 228 | 62(60–67) | 188 | 57(52–62) | |
TB Type | Extra Pulmonary | 126 | 34(30–39) | 89 | 27(23–32) |
MDR-TB | 14 | 4(2–6) | 53 | 16(13–20) | |
Current Smoking | None Smoker | 335 | 91(88–94) | 303 | 92(88–94) |
History | Smoker | 33 | 9(6–12) | 27 | 8(6–12) |
Distance to HC (in | Within Catchment | 352 | 96(93–97) | 302 | 92(88–94) |
km) | Out of Catchment | 16 | 4(3–7) | 28 | 9(6–12) |
Alcohol Use Disorder | No Risk | 307 | 83(79–87) | 286 | 87(83–80) |
There is Risk | 61 | 17(13–21) | 44 | 13(10–18) | |
Psychological | No Symptom | 204 | 55(50–60) | 153 | 46(41–52) |
Distress Symptom | There is Symptom | 164 | 45(40–50) | 177 | 54(48–59) |
Low(0–4) | 138 | 40(33–43) | 137 | 42(36–47) | |
Economic Status | Medium (5–6) | 103 | 30(24–33) | 66 | 20(16–25) |
High(7–10) | 106 | 31(24–34) | 70 | 21(17–26) |
ART- Antiretroviral Therapy
HIV- Human Immunodeficiency Virus